Dapsone Hemolysis Risk and G6PD Screening Tool

Assesses hemolysis risk with dapsone therapy using G6PD enzyme activity level, starting dose, methemoglobin monitoring schedule, and CBC surveillance protocol for dermatological and PCP prophylaxis indications

Each component has a specific meaning:

• G6PD enzyme activity level — The g6pd enzyme activity level recorded for the scenario being assessed.
• Starting dose — The starting dose recorded for the scenario being assessed.
• Methemoglobin monitoring schedule — The methemoglobin monitoring schedule recorded for the scenario being assessed.
• CBC surveillance protocol — The cbc surveillance protocol recorded for the scenario being assessed.

Note: Interpret the dapsone g6pd risk result against the thresholds and context described above.

Enter the G6PD enzyme activity level, starting dose, methemoglobin monitoring schedule, CBC surveillance protocol for the scenario you are assessing. Assesses hemolysis risk with dapsone therapy using G6PD enzyme activity level, starting dose, methemoglobin monitoring schedule, and CBC surveillance protocol for dermatological and PCP prophylaxis indications. Use the dapsone g6pd risk result to inform your calculation.